Standard

Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. / Kondakova, Ekaterina A.; Golosova, Natalia N.; Kravchuk, Bogdana I. и др.

в: International Journal of Molecular Sciences, Том 27, № 12, 5466, 17.06.2026.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Kondakova, EA, Golosova, NN, Kravchuk, BI, Khlusevich, YA, Yakubovskij, VI, Kozlova, YN, Grishkova, SA, Tikunova, NV & Matveev, AL 2026, 'Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae', International Journal of Molecular Sciences, Том. 27, № 12, 5466. https://doi.org/10.3390/ijms27125466

APA

Kondakova, E. A., Golosova, N. N., Kravchuk, B. I., Khlusevich, Y. A., Yakubovskij, V. I., Kozlova, Y. N., Grishkova, S. A., Tikunova, N. V., & Matveev, A. L. (2026). Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. International Journal of Molecular Sciences, 27(12), [5466]. https://doi.org/10.3390/ijms27125466

Vancouver

Kondakova EA, Golosova NN, Kravchuk BI, Khlusevich YA, Yakubovskij VI, Kozlova YN и др. Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. International Journal of Molecular Sciences. 2026 июнь 17;27(12):5466. doi: 10.3390/ijms27125466

Author

Kondakova, Ekaterina A. ; Golosova, Natalia N. ; Kravchuk, Bogdana I. и др. / Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. в: International Journal of Molecular Sciences. 2026 ; Том 27, № 12.

BibTeX

@article{7369e28028454c0bae1c45f87fb0ca20,
title = "Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae",
abstract = "Multidrug resistance (MDR) is a global problem for the healthcare system, complicating the therapy of bacterial infections. It is noted that patients infected with MDR strains often require prolonged hospitalization, have a high risk of mortality, and remain vulnerable to reinfection after recovery. In this study, recombinant phage-encoded depolymerase DepKP144 was produced using the Escherichia coli expression system and purified. The depolymerase DepKP144 protein was able to reduce viable bacterial counts following capsule degradation in 95% of the tested strains of type K1 and 85% of the tested strains of type K2 Klebsiella pneumoniae. The depolymerase DepKP144 was active against K. pneumoniae K1-type and K2-type planktonic cells and destroyed the biofilms formed by clinical MDR strains of K. pneumoniae. In in vivo experiments, DepKP144 at a dose of 180 μg/mouse resulted in a 50% survival of the mice infected with K2-type K. pneumoniae and in a 17% survival of the mice infected with K1-type K. pneumoniae. This depolymerase is promising for further development of prevention and therapeutic candidates against MDR K. pneumoniae.",
keywords = "K. pneumoniae, K1-type, K2-type, Klebsiella pneumoniae, antibacterials, biofilm degradation, capsular polysaccharide, depolymerase, multi drug resistance, Klebsiella pneumoniae, деполимераза, множественная лекарственная устойчивость, антибактериальные средства, тип K1, тип K2, капсульный полисахарид, разрушение биопленок, K. pneumoniae",
author = "Kondakova, {Ekaterina A.} and Golosova, {Natalia N.} and Kravchuk, {Bogdana I.} and Khlusevich, {Yana A.} and Yakubovskij, {Vyacheslav I.} and Kozlova, {Yuliya N.} and Grishkova, {Svetlana A.} and Tikunova, {Nina V.} and Matveev, {Andrey L.}",
note = "Kondakova, E.A.; Golosova, N.N.; Kravchuk, B.I.; Khlusevich, Y.A.; Yakubovskij, V.I.; Kozlova, Y.N.; Grishkova, S.A.; Tikunova, N.V.; Matveev, A.L. Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. Int. J. Mol. Sci. 2026, 27, 5466. https://doi.org/10.3390/ijms27125466 This research was funded by the Russian Science Foundation, grant number 23-74-10105, https://rscf.ru/project/23-74-10105/ (access date 21 January 2026). The work on the cultivation of bacterial strains and the establishment of the in vivo model was supported by the Ministry of Education and Science, Project No. 125041005114-8.",
year = "2026",
month = jun,
day = "17",
doi = "10.3390/ijms27125466",
language = "English",
volume = "27",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

RIS

TY - JOUR

T1 - Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae

AU - Kondakova, Ekaterina A.

AU - Golosova, Natalia N.

AU - Kravchuk, Bogdana I.

AU - Khlusevich, Yana A.

AU - Yakubovskij, Vyacheslav I.

AU - Kozlova, Yuliya N.

AU - Grishkova, Svetlana A.

AU - Tikunova, Nina V.

AU - Matveev, Andrey L.

N1 - Kondakova, E.A.; Golosova, N.N.; Kravchuk, B.I.; Khlusevich, Y.A.; Yakubovskij, V.I.; Kozlova, Y.N.; Grishkova, S.A.; Tikunova, N.V.; Matveev, A.L. Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. Int. J. Mol. Sci. 2026, 27, 5466. https://doi.org/10.3390/ijms27125466 This research was funded by the Russian Science Foundation, grant number 23-74-10105, https://rscf.ru/project/23-74-10105/ (access date 21 January 2026). The work on the cultivation of bacterial strains and the establishment of the in vivo model was supported by the Ministry of Education and Science, Project No. 125041005114-8.

PY - 2026/6/17

Y1 - 2026/6/17

N2 - Multidrug resistance (MDR) is a global problem for the healthcare system, complicating the therapy of bacterial infections. It is noted that patients infected with MDR strains often require prolonged hospitalization, have a high risk of mortality, and remain vulnerable to reinfection after recovery. In this study, recombinant phage-encoded depolymerase DepKP144 was produced using the Escherichia coli expression system and purified. The depolymerase DepKP144 protein was able to reduce viable bacterial counts following capsule degradation in 95% of the tested strains of type K1 and 85% of the tested strains of type K2 Klebsiella pneumoniae. The depolymerase DepKP144 was active against K. pneumoniae K1-type and K2-type planktonic cells and destroyed the biofilms formed by clinical MDR strains of K. pneumoniae. In in vivo experiments, DepKP144 at a dose of 180 μg/mouse resulted in a 50% survival of the mice infected with K2-type K. pneumoniae and in a 17% survival of the mice infected with K1-type K. pneumoniae. This depolymerase is promising for further development of prevention and therapeutic candidates against MDR K. pneumoniae.

AB - Multidrug resistance (MDR) is a global problem for the healthcare system, complicating the therapy of bacterial infections. It is noted that patients infected with MDR strains often require prolonged hospitalization, have a high risk of mortality, and remain vulnerable to reinfection after recovery. In this study, recombinant phage-encoded depolymerase DepKP144 was produced using the Escherichia coli expression system and purified. The depolymerase DepKP144 protein was able to reduce viable bacterial counts following capsule degradation in 95% of the tested strains of type K1 and 85% of the tested strains of type K2 Klebsiella pneumoniae. The depolymerase DepKP144 was active against K. pneumoniae K1-type and K2-type planktonic cells and destroyed the biofilms formed by clinical MDR strains of K. pneumoniae. In in vivo experiments, DepKP144 at a dose of 180 μg/mouse resulted in a 50% survival of the mice infected with K2-type K. pneumoniae and in a 17% survival of the mice infected with K1-type K. pneumoniae. This depolymerase is promising for further development of prevention and therapeutic candidates against MDR K. pneumoniae.

KW - K. pneumoniae

KW - K1-type

KW - K2-type

KW - Klebsiella pneumoniae

KW - antibacterials

KW - biofilm degradation

KW - capsular polysaccharide

KW - depolymerase

KW - multi drug resistance

KW - Klebsiella pneumoniae

KW - деполимераза

KW - множественная лекарственная устойчивость

KW - антибактериальные средства

KW - тип K1

KW - тип K2

KW - капсульный полисахарид

KW - разрушение биопленок

KW - K. pneumoniae

UR - https://www.mendeley.com/catalogue/8c952cc4-c68f-3d6b-ad3e-1e07fa1dac34/

UR - https://www.scopus.com/pages/publications/105042948030

U2 - 10.3390/ijms27125466

DO - 10.3390/ijms27125466

M3 - Article

C2 - 42353184

VL - 27

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

M1 - 5466

ER -

ID: 85412706